Intuitive Surgical, Inc.

NASDAQ Global Select
Somewhat Bearish -30

Intuitive Surgical stock heads into the open after a 2.9% slide

πŸ“‰ Intuitive Surgical stock closed down 2.9% at USD 366.70 on September 4, 2026.

πŸ“Š Shares are trading approximately 39% below their 52-week high of USD 603.88.

πŸ“‰ The stock has declined roughly 21.5% over the past twelve months.

πŸ’° Intuitive Surgical maintains a market capitalization of around USD 131.38 billion.

🎯 Analyst consensus suggests an average price target near USD 508.68, indicating the current price is below expectations.

πŸ“‰ The company underperformed the broader Nasdaq Composite and healthcare indices during the session.

πŸ“… No earnings reports or major corporate events are scheduled for the immediate future.

Bullish Signals
  • Intuitive Surgical trades at a discount relative to analyst consensus, with an average price target near USD 508.68 suggesting potential upside from current levels.
  • The company maintains a robust market capitalization of approximately USD 131.38 billion, indicating strong overall market valuation despite recent short-term declines.
Risk Factors
  • Intuitive Surgical shares closed down 2.9% and are trading roughly 39% below their 52-week high.
  • The stock has experienced a significant drawdown of approximately 21.5% over the past twelve months.
  • Intuitive Surgical underperformed the broader Nasdaq Composite index and the wider healthcare sector during the trading session.
Full Analysis
Intuitive Surgical (ISRG) shares closed on September 4, 2026, at USD 366.70 on the Nasdaq, marking a 2.9% decline from the prior session. The stock finished significantly below its recent peak, trading approximately 39% under its 52-week high of roughly USD 603.88 and down about 21.5% over the past twelve months. Despite the recent price weakness, market data indicates that Intuitive Surgical trades at a discount relative to analyst consensus, with an average price target near USD 508.68. The company maintains a substantial market capitalization of approximately USD 131.38 billion, reflecting its status as a major player in the medical technology sector. Trading volume for the session remained consistent with recent patterns, though Intuitive Surgical underperformed the broader Nasdaq Composite index and the wider healthcare cohort. With no company-specific earnings reports or scheduled events imminent, near-term stock movements are expected to be driven primarily by broader market dynamics, sector performance, and macroeconomic indicators rather than specific corporate developments.